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Summary Permanent cell lines (UCT-Mel 1 through 7) were established from biopsies of metastatic tissue
taken from seven patients with malignant melanoma. Cells from these lines were all aneuploid and all grew as
non-contact-inhibited, adherent monolayers. All of the lines, with the remarkable exception of UCT-Mel 6,
formed tumours in nude mice, expressed the melanoma M-18 antigen and synthesized plasminogen activators
exclusively of the tissue-type. UCT-Mel 6 cells were non tumourigenic, they lacked the M-18 antigen and they
synthesized plasminogen activators exclusively of the urokinase type. UCT-Mel I and UCT-Mel 2 formed
pigment in vitro and both of these lines showed an increase in pigment content and tyrosinase synthesis with
increasing cell density. The rate of plasminogen activator released by UCT-Mel 1 and UCT-Mel 3 declined
strikingly as the cells became confluent.
Assuming (a) that proteolytic activity is required for cell migration in vivo; (b) that tyrosinase synthesis
reflects expression of the differentiated phenotype and (c) that melanoma cells retain some of the
characteristics of neural crest cells, we suggest that the effects of confluence and close cell-cell contact provide
a useful experimental counterpart for the study of normal neural crest all behaviour that is characterized by
an inverse relationship between migration and a protease secretion on the one hand and pigmentation on the
other.
Human melanoma cells cultured in vitro provide a
useful system for examining processes that are
relevant both to this particular class of tumours
and, at the same time, to cellular biological pheno-
mena of a more general nature.
Melanogenesis, for example, is an obvious and
readily quantifiable marker of cellular differen-
tiation that can be used to study factors that govern
expression ofthedifferentiated phenotypein pigment-
ing cell lines. Furthermore, as derivatives of the
embryonic neural crest, melanoma cells share a
common origin with a variety of ectomesenchymal
structures, cells of the autonomic nervous system,
calcitonin-producing cells, cells of the carotid body
and sensory neurones in spinal ganglia and cranial
nerves. It is now clear that, in choosing one of
these diverse alternative destinies, pluripotential
neural crest 'stem-cells' are influenced by environ-
mental cues that come from neighbouring em-
bryonic structures (Le Douarin, 1982). Melanoma
cells thus offer potential for studying cellular inter-
actions that influence morphogenesis or commit-
ment to a particular developmental programme.
Finally, as with other neural crest cells, pre-
melanocytes are remarkable for their striking ability
to migrate to distant target organs where they
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assume residence and complete their terminal dif-
ferentiation. These invasive and organotropic at-
tributes have obvious implications for the study of
tumour spread and correlate well with the known
tendency of malignant melanomas to metastasize
in vivo.
For these reasons the development and charac-
terization of human melanoma cell lines is desirable.
In this paper we report the isolation of seven such
lines, each of which was derived from a different
patient. The cultured cells displayed features that
emphasize the heterogeneity that is observed when
different lines are compared and yet, at the same
time, the remarkably consistent pattern of behaviour
of each cell line when considered individually.
Several of these lines clearly possess stable
properties that identify them as valuable material
for further study.
Materials and methods
Cell cultures
Specimens of metastatic melanoma tissue (regional
lymph nodes in 5 cases; brain in 1 case; and liver in
1 case;) were obtained from patients at the time of
surgery. These were transported to the laboratory
and established in primary culture as previously
described (Wilson & Dowdle, 1978).
Cells were cultured routinely in Dulbecco's
modified Eagle's medium or RPMI-1640 medium
(Grand Island Biological Company, Grand Island,
New York) containing heat-inactivated foetal calf
© The Macmillan Press Ltd., 1986288 E.G. HOAL-VAN HELDEN et al.
serum (State Vaccine Laboratories, Cape Town),
300 g penicillin ml-1, 200, g streptomycin sulphate
ml-1 and 10 yg tylocineml-1. Cultures were main-
tained at 37°C in a humid atmosphere containing
5% CO2 in air.
Culture media were changed twice weekly.
Confluent adherent cultures were passaged by
detachment with 0.25% trypsin and 0.02% EDTA
in Tris-buffered saline (TBS: 0.137MNaCl,
5mM KCl, 0.7mM Na Phosphate, 25mM Tris-
HCl; pH7.4) and re-seeding at -2x 105 cells/
35mm dish.
Cell lines were tested for mycoplasma contamina-
tion (Chen, 1977) and found to be negative.
Growth curves were constructed by seeding cells
at a low density (usually 105 cells/35mm dish) and
feeding with fresh medium every 48h. Cells in
duplicate dishes were detached at 48h intervals and
counted.
Cells were tested for anchorage-independent
growth in agar by the method of MacPherson
(1973).
Growth in nude mice
Cells were trypsinized, pelleted and washed once
with complete medium. Thymus-deficient mice of
the N: NIH(s)II-nu/nu strain (Azar et al., 1980)
received subcutaneous inocula containing 106 or
5 x 106 cells. The mice were observed for at least 3
months for the appearance of tumours.
Melanin, tyrosinase andplasminogen activator
The melanin content of pelleted cells was scored by
inspection as negative, moderate or marked. Mono-
layer cultures were rinsed with cold PBS and
scraped with a Teflon policeman into a small
volume of PBS. Detached cells were washed with
PBS and lysed by the addition of 0.5% Triton
X-100 in water to the final pellet. The lysate was
stored at -20°C until used for the measurement of
plasminogen activator activity as described below
or for the fluorometric assay of tyrosinase content
by the method of Adachi and Halprin (1967).
Enzyme activity was related to the protein content
of the cell lysate as measured fluorometrically
(Boplen et al., 1973) using bovine serum albumin as
a standard.
Serum-free melanoma-cell conditioned media
were collected and stored as previously described
(Wilson et al., 1980). The plasminogen activator
content was measured as the rate of plasminogen-
dependent release of soluble radioactive fibrin
degradation peptides from insoluble 1251-labelled
fibrin adsorbed to Linbro multiwell plates (Wilson
& Dowdle, 1978).
Electrophoresis of plasminogen activators in
polyacrylamide gels containing sodium dodecyl
sulphate (SDS-PAGE) and the subsequent zymo-
graphic detection of the enzyme bands by over-
laying the polyacrylamide gels on agar indicator
gels containing plasminogen and fibrin were
performed as described (Granelli-Piperno & Reich,
1978; Wilson et al., 1983). Relative molecular
mass (Mr) was calculated by reference to co-
electrophoresed molecular weight marker proteins.
Immunochemical identification of plasminogen
activator type was achieved with inhibitory anti-
bodies to human urokinase or human tissue plas-
minogen activator (Wilson et al., 1980; Wilson et
al., 1983).
Melanoma M-18 surface antigen
A sample of the monoclonal antibody R24 was
generously provided by Dr A. Houghton of the
Memorial Sloan-Kettering Cancer Center, 1275
York Avenue, New York 10021. This antibody
binds to the M-18 antigen that was present on all
melanoma cells tested by him (Houghton et al.,
1982). We detected the antigen on cultured cells
with a roesetting procedure (Dippold et al., 1980) in
which cells were incubated with the antibody,
washed, and then incubated with indicator human
erythrocytes to which staphylococcal protein A had
been conjugated. Results were scored visually on a
scale from '-' (negative) to '++ +' (strongly
positive).
Results
Cell lines
Permanent melanoma cell lines (designated UCT-
Mel 1 through 7) were established from biopsy
samples of metastatic deposits from 7 patients with
the disease. A summary of the characteristics of
these lines is presented in Table I.
All cell lines grew as adherent monolayers with a
characteristic cuboidal, dendritic, or spindle cell
morphology (Figure 1). None exhibited contact
inhibition. In some cases (UCT-Mel 1,2,3, 5 and 7)
the cells formed large multilayered clumps, while in
other cases (UCT-Mel 4 and 6) the cells formed a
tightly packed monolayer. With the exception of
UCT-Mel 6, all of the cell lines expressed the M-18
antigen.
Growth rates varied widely between the cell lines
(doubling times in RPMI 1640 medium containing
10% FCS ranged from 33h to 95h) but little
within-line variation was observed. Doubling times
in RPMI-1640 medium were either shorter or the
same as those observed in DME and cells grew to
higher saturation densities in this medium. In oneMELANOMA CELL PLASMINOGEN ACTIVATORS AND TYROSINASE 289
Table I Growth characteristics of melanoma cell lines
UCT-Mel I UCT-Mel 2 UCT-Mel 3 UCT-Mel 4 UCT-Mel S UCT-Mel 6 UCT-Mel 7
Generation time (hr) 41 50 50 52 58 33 95
Saturation density
(cellsx 10-5cm-2) 3.6 3.0 1.7 3.8 3.1 2.8 1.6
Growth in soft agar (%) 57.4 63.2 53.8 oa 18.6 oa 1.8
Pigmentation'
In vivo + + - + - -
In vitro + +
Growth in nude mice + + + + + - +
Plasminogen activator
U 10-6 cells 24h h1 18.6 ± 1.8(62) 4.3+0.4(61) 9.1 + 1.1(43) 30.7+4.5(16) 6.8+2(16) 674+9.2(9) 8.9+2.4(25)
Type t-PA t-PA t-PA t-PA t-PA u-PA t-PA
Melanoma M-18
antigen ++++ ++ ++++ + + - ++
aCells seeded with fibroblast feeder layer. "The melanin content of the original biopsy specimen and of the pelleted cells
were assessed visually. cValues given as mean+s.d.; number of determinations in parenthesis.
case (UCT-Mel4) DME appeared to be toxic to the
cells.
All of the lines, with the exception of UCT-Mel 4
and UCT-Mel 6, showed some degree of
anchorage-independent growth. All except UCT-
Mel 6 formed tumours when inoculated into nude
mice.
Melanin and tyrosinase production
Of the seven cell lines studied, only two (UCT-
Mel 1 and UCT-Mel 2) that were derived from
pigmented biopsy samples, produced detectable
melanin or tyrosinase in culture. In both cases,
cellular pigmentation increased as the cells became
confluent, being most striking in the multilayered
clumps of cells that formed. This increase in
melanin synthesis with increased cell density was
accompanied by a parallel increase in tyrosinase
synthesis (Figure 2). Cells grown in RPMI showed
less pigmentation than those cultured in DME. As
previously reported (Hoal et al., 1982) the density
dependent increase in the rate of tyrosinase syn-
thesis by UCT-Mel 2 could be inhibited by 10-6 M
retinoic acid. UCT-Mel 4 cells, although derived
from tissue that was pigmented in vivo, lost the
pigmented phenotype in vitro.
Plasminogen activator species andproduction
All of the melanoma cell lines released plasminogen
activators at consistent although different rates. In
no case was plasminogen-independent fibrinolytic
activity detected. Plasminogen activators synthesised
by six of the cell lines were completely inhibited
by antibody to tissue plasminogen activator and
showed a predominant Mr on SDS-PAGE of
- 70,000. UCT-Mel 6 was exceptional in this regard.
These cells released plasminogen activators that
migrated electrophoretically as a prominent doublet
with an Mr of -60,000 and that were inhibited
by antibody to urokinase.
In addition to the major 70,000 Mr component,
enzymes of the tissue plasminogen activator type
usually included several other species. A 60,000 Mr
band was prominent in zymograms of harvest fluid
enzymes while it was characteristically absent in
those of cell lysates. Intracellular tissue plasmino-
gen activators, on the other hand, included a faint
58,000 Mr species that only became apparent after
prolonged incubation of the zymogram. All of the
harvest fluids and the cell lysates contained small
amounts of a 100,000 Mr enzyme that required a
long period of incubation to become visible.
Occasionally a faint 38,000 band was also seen.
These patterns are shown in Figure 3. The relative
amounts of each plasminogen -activator species
released into the harvest fluids were different and
characteristic for each cell line (Figure 4).
The urokinase type enzymes synthesised by UCT-
Mel6 included, in addition to the major 60,000Mr
doublet, small amounts of enzyme with an Mr of
-100,000. These were present in both harvest
fluids and cellular extracts.
The rate at which plasminogen activator accumu-
lated in the medium covering UCT-Mel 1 or UCT-
Mel 3 was not linearly related to the number of
cells in the dish. As cell density increased so the
rate of accumulation of enzyme per 106 cells
diminished. This effect was not seen in the case of
UCT-Mel 2 (Figure 2). When confluent cultures
were dispersed with trypsin or EDTA and re-seeded
at low densities, the rate at which enzyme accumu-
lated in the medium was restored, within 24h, to
the previously high subconfluent rate.290 E.G. HOAL-VAN HELDEN et al.
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Figure 1 Microscopic appearance of human melanoma cell lines UCT-Mel I through 7. Marker 50psm.
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Figure 2 Plasminogen activator release and cellular
tyrosinase content as a function of cell density. Cul-
tures of the three melanoma cell lines were established.
At the cell densities indicated, replicate cultures were
used to collect serum-free harvest fluids for plasmino-
gen activator measurement. The cells were then harves-
ted for counting and for measurement of tyrosinase
content.
Increasing cell density affected only the rate of
plasminogen activator release into the medium; the
intracellular concentration of enzyme remained
unchanged. In the case of UCT-Mel 1, for example,
the rate of plasminogen activator release fell from
57 units 10-6 cells 24h-1 in sparse cultures to 0.8
units 10 6 cells 24h-1 at confluence (Figure 2).
The corresponding intracellular enzyme concen-
trations were 20.2 units mg-' cell protein and 19.6
units mg- 1 cell protein respectively. UCT-Mel 3
showed a similar lack of relationship between cell
density and intracellular plasminogen activator
content.
Loskutoff et al. (1983) and Levin (1983) have
shown that certain cells release inhibitors of
plasminogen activators into the medium into which
they are cultured. It occurred to us that the fall in
enzyme activity that we observed might be caused
by a density-dependent increase in the synthesis and
release of such an inhibitor. We accordingly
performed mixing experiments in which harvest
fluids from confluent cultures were added to those
from sparse cultures and enzyme contents were
measured before and after mixing. No inhibitory
effect of the media from confluent cultures could be
demonstrated.
Discussion
The general observations that we record in this
paper are in close agreement with those of others
who have established cell lines from biopsies of
human melanomas (Creasy et al., 1979; Gerner et
al., 1979; Giovanella et al., 1976; Liao et al., 1975).
One may summarise this collective experience by
stating that these cell lines usually have an
abnormal karyotype and differ widely in their
growth characteristics. While it is not unusual for
melanoma cell lines to synthesize melanin in vitro,
the amelanotic phenotype is more commonly seen.
Although the biochemistry of melanin synthesis is
well understood, the processes that regulate
melanogenesis are not known, nor is it known if
the frequent failure of melanoma cells to pigment
represents a genetic loss of the apparatus for
melanin and melanosome synthesis or a failure on
the part of the malignant cell to complete the
process of terminal differentiation that is normally
observed when the immature melanocyte penetrates
the epidermal basement membrane and responds to
stimuli that come from neighbouring ectodermal
cells (Sober & Fitzpatrick, 1979). This is relevant to
the clinical observation that variegate pigmentation,
with areas of amelanosis, is one of the diagnostic
hallmarks of cutaneous malignant melanoma.
The two cell lines in this series that did pigment
in culture were similar to those described by
Romsdahl and Hsu (1972) and Giovanella et al.
(1976) in that melanogenesis increased with
increasing cell density. In our experience cell
clusters that formed at confluence were particularly
deeply pigmented. When confluent cells or clusters
were dispersed, the rate of cellular melanogenesis
again decreased. It is of interest to note in this
regard that when Glimelius and Weston (1981)
cultured quail neural crest cells under conditions
that prevented dispersal and favoured proliferation
(i.e. on an agar substrate with a high content of
FCS and chick embryo extract) clusters of cells
formed that differentiated into pigmented melano-
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Figure 3 Plasminogen activators present in conditioned medium (a and b) and a lysate of the corresponding
cells (c and d) from the same culture of UCT-Mel 4 cells. Enzyme-containing samples were electrophoresed in
11% polyacrylamide gel slabs containing 1%/ sodium dodecyl sulfate. After electrophoresis the resolved
enzyme bands were detected by incubation on an indicator agar layer containing fibrin and plasminogen.
Photographs were taken, with dark ground illumination, after 1 h at 37°C (a and c). The same lanes were
photographed after a further 6h of incubation (lanes b and d respectively).i,~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s,.,_....
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Figure 4 Molecular species of plasminogen activators present in media conditioned by the seven cell lines
indicated. Electrophoretic and zymographic analysis of the enzyme-containing harvest fluids was performed as
described in Materials and methods and in the legend to Figure 3.MELANOMA CELL PLASMINOGEN ACTIVATORS AND TYROSINASE 293
cytes. A less rich medium and an adherent substrate
selected for cells that migrated and only rarely
synthesized melanin. It seems likely, therefore, that
cellular interactions influence melanogenesis and
that pigmented melanoma cell lines may be used to
investigate the nature of these interactions.
Although the melanoma cell lines that we have
studied differed in many ways, they were
consistently similar in three important respects.
Firstly, and in keeping with previous reports
(Rijken and Collen, 1981; Roblin and Young, 1980;
Tucker et al., 1978; Vetterlein et al., 1980;
Vetterlein et al., 1979; Wilson et al., 1980) all of the
lines, with the exception of UCT-Mel 6, synthesized
plasminogen activators of the tissue type. The fact
that UCT-Mel 6 secreted urokinase may be relevant
to the observations of Markus et al. (1984) who
showed that extracts or primary cultures of
melanoma tissue fragments contained or release
predominantly urokinase. Secondly, all (once again,
with the exception of UCT-Mel 6) possessed the
M-18 surface antigen that is characteristic of
melanoma cells and is found at all stages of
melanocyte differentiation (Houghton et al., 1982).
Finally, all of the lines (again excepting UCT-
Mel 6) were tumourigenic when injected into nude
mice. These observations attest to the usefulness of
tissue plasminogen activator synthesis and M-18
antigen expression as markers for the in vitro
identification of melanoma cells and, at the same
time, emphasize the singularity of UCT-Mel 6.
The biopsy from which UCT-Mel6 was
established came from a patient who had had a
primary malignant melanoma - Clark's level IV -
excised three years previously. Two and three years
after the primary excision, inguinal lymph nodes
showing the presence of secondary melanoma were
removed. UCT-Mel 6 was derived from a biopsy
taken at the second of these two operations. This
cell line was therefore established from a tumour
that was confidently diagnosed as a malignant
melanoma and yet the cells lacked the M-18
antigen and synthesized only urokinase. Un-
fortunately the patient died shortly after the
tumour specimen was obtained and we were unable
to procure confirmatory tissue or to seek further
clinical features that might have explained these
anomalies. Two possibilities clearly exist. Either the
clinical and histological diagnosis of malignant
melanoma was incorrect or, alternatively, an
unusual subtype of human malignant melanoma
cell lines can be defined by the absence of the M-18
antigen and the secretion of urokinase. In a
thoughtful presentation of their observations,
Markus et al (1984) suggested that selection for
indefinite growth in vitro selected against urokinase-
producing melanoma cells and favoured those that
release tissue activator. UCT-Mel 6 may thus have
escaped these selection pressures. The identification
of other similar melanoma cell lines and the results
of applying other 'melanoma-specific' tests to the
UCT-Mel 6 cells may resolve this problem.
Assuming that UCT-Mel 6 cells are, indeed,
melanoma-derived, the singular features of this line
that distinguish it from other melanoma cell lines -
i.e. synthesis and release of urokinase and the
failure to form tumours in the nude mouse- show
that it is possible for different members of a
particular class of tumours to be committed to the
synthesis and release of different types of
plasminogen activator. Furthermore, the type of
enzyme that is made may correlate with the
expression of other characteristics of the malignant
phenotype.
It is of interest to note that, in a different
neoplastic context, we have encountered a similar
example of this principle. We refer to the fact that
the prognosis of patients with acute myeloid
leukaemia whose leukaemic cells synthesize
plasminogen activators that are exclusively of the
tissue type is worse than that ofpatients whose cells
secrete urokinase (Wilson et al., 1983). It would be
of considerable clinical and experimental value if
the determination of plasminogen activator type
could be applied to the diagnosis, prognosis and
management of other tumours.
We are not, at this stage, able to comment
definitively on the mechanisms responsible for the
multiple Mr forms of plasminogen activators that
we have observed. Since the first human tissue
plasminogen activator gene to be cloned coded for
a polypeptide with a molecular mass of -63,000
daltons (Pennica et al., 1983), we feel that it is
improbable that the 100,000 Mr species is a
precursor of the lower molecular weight forms. We
feel that it is more likely that it represents an
enzymatically active complex formed by the
combination of the enzyme with a specific binding
molecule similar to the one that we have previously
described on fibroblasts (Hoal et al., 1983) or that
Levin has described as a 40,000 dalton inhibitor
that binds to tissue plasminogen activator and
converts it to an inactive or 'latent' species (Levin,
1983).
Two of the lines (UCT-Mel 1 and UCT-Mel 3),
showed a striking fall in the rate of plasminogen
activator release into the medium with increasing
cell density similar to that observed by Chou et al.
(1977) with cultured 3T3 cells. We were unable to
demonstrate the release of an inhibitor of plasmin
or plasminogen activator by confluent cells, nor did
such cells accumulate enzyme intracellularly.
Enzyme inhibition or a secretory block do not,
therefore, appear to be explanations for this294 E.G. HOAL-VAN HELDEN et al.
phenomenon and we tentatively conclude that
enzyme synthesis is inhibited in confluent cultures
or that confluent cells express a receptor for tissue
plasminogen activator similar to the fibroblast
receptor (Hoal et al., 1983) and that enzyme is
removed by this mechanism. Studies are currently
under way to exanine these two alternatives.
Although one cannot assign a definite function to
the plasminogen activators that are made by
melanoma cells, it is known that neural crest cells,
and particularly melanoblasts, have a remarkable
capacity for migration through the tissues of the
embryo (Le Douarin, 1982). These enzymes may be
involved in this phenomenon. Detachment of
migrating melanoblasts from the crest, their long
and invasive journey through mesenchymal tissues
and, finally, their penetration of the epidermal
basement membrane, all suggest the need for some
form of regulated proteolytic process. Reich (1978)
has suggested that plasminogen activators provide
the proteolytic potential that is required-for cellular
traversal of tissue barriers, and our observations
with cells derived from metastatic melanomas are in
accord with this suggestion. Furthermore, one
would expect that cells that had reached their
epidermal destination and converted to a resident
programme of terminal differentiation, would
reduce plasminogen activator synthesis. We have
suggested above that in vitro confluence regulates
melanin synthesis by providing stimnuli that mimic
those provided by the environment of the
epidermis. By the same token, similar stimuli would
be expected to cause the density-dependent decline
in cellular plasminogen activator release that we
have noted.
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